Catch up on the most-well viewed radiology content in September 2024.

The addition of parameters such as patient age, MIP sign and associated imaging features to the Kaiser score demonstrated a 95.6 percent AUC for breast cancer detection of enhancing lesions on breast MRI in recently published research.

Catch up on the most-well viewed prostate imaging content in September 2024.

Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.

Catch up on the top AI-related news and research in radiology over the past month.

Irrespective of differences with radiation dosing and tube voltage, obtaining CT-derived fat fraction from photon-counting detector CT provides consistently comparative results to MRI-derived proton density fat fraction assessment, according to new research.

A new meta-analysis found that PSMA PET/CT offers a 12 percent higher positivity rate for detecting biochemical recurrence of PCa and a 19 percent higher positivity rate for identifying lymph node metastasis in comparison to mpMRI.

The Piur tUS Infinity system reportedly reduces operator dependency with ultrasound through upgrading of two-dimensional ultrasound devices and access to 3D multiplanar image reconstructions of thyroid conditions.

For patients who had neuroradiological trauma CT scans, researchers noted no significant visual differences between deep learning denoising at 25% mAs and iterative reconstruction at 100% mAs.

How does one reconcile being reachable by fellow clinicians and an inevitable invasion of privacy?

Catch up on the top radiology content of the past week.

While researchers noted no significant impact on sensitivity rates, they found that access to a patient’s prior mammograms resulted in a nearly 15 percent increase in sensitivity for current mammography interpretation.

The CINA-CSpine AI software reportedly demonstrated a 90.3 percent sensitivity rate for cervical spine fractures in validation testing on more than 300 non-contrast CT scans.

The use of 177Lu-PSMA-617 was associated with a significantly longer radiographic progression-free survival and a 12 percent lower rate of grade 3 or higher adverse events in comparison to a change of ARPI therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).

Emphasizing multi-structure segmentation and feature extraction from chest CT scans, an emerging AI model demonstrated an approximately 70 percent AUC for predicting significant incidental extrapulmonary findings as well as two-year and 10-year all-cause mortality.

Now available with MIMneuro, the Centiloid scaling software provides automated quantitative assessment of amyloid plaque density, a key component of Alzheimer’s disease.

In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.

Providing automated TI-RADS classifications and worksheets, the new AI-enabled software may facilitate improved efficiency with thyroid ultrasound exams.

Radiomics models offered a pooled AUC of 86 percent for differentiating between ruptured and unruptured intracranial aneurysms, according to a recently published meta-analysis.

For patients with metastatic castration-resistant prostate cancer (mCRPC) and bone metastasis, the combination of enzalutamide and Ra223 led to a median overall survival rate of 42.3 months in contrast to 35 months for enzalutamide alone, according to research presented at the 2024 European Society for Medical Oncology Congress (ESMO) in Spain.